News and
Insights

Scientific insights

BLOOD AND PLASMA DONATION IN ITALY: SOLIDARITY AT THE SERVICE OF HEALTH

The plasma-derived factor VIII used in both replacement therapy and ITI (immune tolerance induction) therapy is a medicinal product extracted from plasma, a starting material that can only be obtained by donation from healthy individuals. The systems and laws governing blood and plasma donation vary greatly from one country to another. In some countries, such...
Read all

DIAGNOSING INHIBITORS: A SIMPLE TEST MAKES IT POSSIBLE TO DEFEAT THEM IN TIME

For any patient with haemophilia A, the presence of factor VIII inhibitors represents the greatest threat to be overcome. Inhibitors may vanquish the efficacy of replacement therapy and leave the patient completely defenceless with regard to the risk of bleeds. The presence of factor VIII inhibitors can be diagnosed in two ways: incidentally, when a...
Read all

ANTITHROMBOTICS AND HAEMOPHILIA: PREVENTING CARDIOVASCULAR DISORDERS WITH THE AID OF REPLACEMENT THERAPY

For haemophliacs, the third age may bring new health challenges. During this phase of life, there is a greater likelihood of encountering particular circumstances that require the use of medicinal products that are able to interfere with the blood clotting process, such as antithrombotics. The purpose of this class of medicine is to prevent the...
Read all